CONOLIDINE NO FURTHER A MYSTERY

In a very new review, we claimed the identification and the characterization of a brand new atypical opioid receptor with exclusive adverse regulatory Houses in the direction of opioid peptides.1 Our success showed that ACKR3/CXCR7, hitherto known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is also a wide-spectrum scavenger